New Zealanders are dying – so why the delay on KEYTRUDA?

Monday 19th November 2018 – Following a historic decision by Australia to fund untreated lung cancer patients, Lung Foundation New Zealand says it is extremely disappointed that Pharmac has made no decision on KEYTRUDA two years after making a funding application.

2018 19th November – Lung Foundation Media Release